Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05744557 · ClinicalTrials.gov registry record · NA
Vapocoolant Analgesia for Breast Lymphoscintigraphy
A NA study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05744557: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.
NCT05744557 is a NA study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05744557, a NA study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
To learn if applying vapocoolant anesthetic spray ("Nüm") on the surface of the intended injection site will reduce the pain/anxiety associated with breast injections.
Interventions
- OTHER num Vapocoolant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2025-05-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05744557
The ClinicalTrials.gov registry entry for NCT05744557 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which num Vapocoolant is the first listed.
NCT05744557 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05744557 about?
NCT05744557 is a clinical study titled "Vapocoolant Analgesia for Breast Lymphoscintigraphy". To learn if applying vapocoolant anesthetic spray ("Nüm") on the surface of the intended injection site will reduce the pain/anxiety associated with breast injections.
What is the current status of trial NCT05744557?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2023-03-01. Estimated completion is 2025-05-13.
What interventions are being tested in trial NCT05744557?
The interventions under investigation include: num Vapocoolant (OTHER).
Who is sponsoring clinical trial NCT05744557?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.